Glycodendrimeric ligands of c-type lectin receptors as therapeutic agents in experimental cancer

Adv Exp Med Biol. 2001:495:343-7. doi: 10.1007/978-1-4615-0685-0_48.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Surface / metabolism
  • Colorectal Neoplasms / immunology
  • Colorectal Neoplasms / therapy
  • Glycoconjugates / chemistry
  • Glycoconjugates / immunology
  • Glycoconjugates / therapeutic use
  • Glycosylation
  • Immunotherapy
  • Killer Cells, Natural / immunology
  • Lectins / chemistry
  • Lectins / metabolism*
  • Lectins, C-Type
  • Ligands
  • Melanoma, Experimental / immunology
  • Melanoma, Experimental / therapy
  • Mice
  • Mice, Inbred C57BL
  • NK Cell Lectin-Like Receptor Subfamily B
  • Rats
  • Receptors, Mitogen / metabolism*

Substances

  • Antigens, Surface
  • Glycoconjugates
  • Lectins
  • Lectins, C-Type
  • Ligands
  • NK Cell Lectin-Like Receptor Subfamily B
  • Receptors, Mitogen